Login
Register
Favorite (
0
)
Shopping Cart
0 item(s) $0.00
MENU
+
Tissue Array
+
Tissue Sections
Paraffin Tissue Sections
+
Human Adult Cancer-HuCAT
Human Adult Normal-HuFPT
Monkey (Cynomolgus) (Normal)-CyFPT
Monkey (Rhesus) (Normal)-RsFPT
Mouse (Normal)-MoFPT
Paired Cancer And Normal-NCT
Rat (Normal)-RaFPT
+
Services
IHC and ISH
IHC
Histology Services
+
Support
Selected References
US Biomax for tissue arrays
+
Contact Us
Distributors for US Biomax
+
FAQs
+
Home
Search
Human Paraffin Embedded Tissue Array (1615 Types)
Cell Arrays (0)
Dog Arrays (2)
Monkey Arrays (6)
Mouse Arrays (9)
Rat Arrays (9)
Frozen Tissue Arrays (25)
Search in subcategories
Search in product descriptions
In Stock
Low In Stock
Out Of Stock
Product Compare (0)
Show:
25
50
75
100
>100
Thumb
Name
Description
Cores
Cases
Price
Unstained
H&E
Trial
BR952
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER/PR/p53 IHC results and survival data, 31 cases/95 cores
95
31
$395.00
CO952
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores, replaced by CO952a
95
30
$1,195.00
$1,195.00
CO952a
Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores.
95
30
$1,195.00
$1,195.00
CO953
Colon cancer tissue array with matched normal adjacent and matched or unmatched metastatic carcinoma tissue, with TNM, clinical stage and survival data, 39 cases/95 cores, replacing CO952a
95
39
$1,195.00
$1,195.00
CO953a
Colon adenocarcinoma and metastatic adenocarcinoma tissue array, with matched colon tissue, including survival data, pathology grade, TNM and clinical stage, 39 cases/96 cores, replacing CO953
96
39
$1,195.00
$1,195.00
FeOrg-N090-01
adrenal, kidney, bladder, ureter, pituitary, cerebrum, hippocampus, thalamus, spinal cord, nerve, thymus, spleen, diaphragm, sternum, rib, skin.
90
5
$420.00
$420.00
HBiDC122Su01
Bile ducts cancer, 91 cases.31 cases have tumor and matched NAT*, 60 cases have tumor. With survival information. Follow up 5-9 years. Relapse information available.
122
91
$937.50
$937.50
HBla-Uro105Sur-01
Bladder cancer tissue array, 59 cases. 46 cases have tumor and matched normal adjacent tissue (NAT)
105
59
$780.00
$780.00
HBlaU066Su01
Bladder carcinoma tissue microarray (56 cases) and normal adjacent tissue. With survival data. Replaces HBla-Uro105Sur-01
66
56
$547.00
$547.00
HBraG177Su01
Glioma 177 cases with survival information:tumor (1 core/case).With survival information. Follow up 5-9 years. Relapse information available.
177
177
$2,344.00
$2,344.00
HBre-Duc090Sur-01
Breast tissue array, normal adjacent tissue of HBre-Duc170Sur-01, 90 cases. 1 core/case, with survival information
90
90
$465.00
$465.00
$125.00
HBre-Duc140Sur-02
Breast carcinoma, 140 cases. 1 core/case with survival data
140
140
$1,405.00
$1,405.00
$425.00
HBreD030PG03
30 cases,Carcinoma
30
30
$94.00
$94.00
HBreD070CS02
Breast invasive ductal carcinoma (69 cases) and NAT* (11 cases). 2 cases are from men.
70
70
$234.00
$234.00
HBreD139Su01
Breast carcinoma, 139 cases.With survival information. Follow up 5-9 years. Relapse information available.
139
139
$1,406.00
$1,406.00
HBreD140Su04
Breast carcinoma, 140 cases. With survival information. Follow up 5-9 years. Relapse information available.
140
140
$1,406.00
$1,406.00
HBreD140Su05
Breast carcinoma, 140 cases.With survival information. Follow up 5-9 years. Relapse information available.
140
140
$1,406.00
$1,406.00
HBreD140Su07
Breast cancer tissue array, including pathology grade, TNM and clinical stage (reference AJCC 6th version), survival data (Surgery date 2004.8--2008.12. Visit date 2014.7. Being followed up for 5.6--10 years), and IHC marker (ER, PR, Her-2, Ki67 and P53), 140 cases/140 cores
140
140
$1,414.00
$1,414.00
HBreD145Su01
Breast carcinoma, 145 cases. With survival information. Follow up 5-9 years. Relapse information available.
145
145
$1,562.00
$1,562.00
HBreD145Su02
Breast carcinoma tissue array, 145 cases, 1 core/case. Clinical stage 0, I, II, III. With survival data. Replacing HBre-Duc150Sur-02 (141 same cases)
145
145
$1,484.00
$1,484.00
HCol-Ade180Sur-02
Colon adenocarcinoma tissue array with survival and TNM information.data, 93 cases, 87 cases with tumor and normal adjacent tissue (NAT).
180
93
$1,250.00
$1,250.00
HCol-Ade180Sur-03
Colon cancer tissue array, 90 cases of tumor and matched normal adjacent tissue (1 core/case), with survival data
180
90
$1,090.00
$1,090.00
HCol-Ade180Sur-04
Colon cancer tissue array 90 cases of tumor and matched normal adjacent tissue, respectively (1 core/case)
180
90
$1,250.00
$1,250.00
HCol-Ade180Sur-05
Colon adenocarcinoma,90 cases, tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.
180
90
$1,562.00
$1,562.00
HCol-Ade180Sur-08
Colon cancer tissue array 90 cases of tumor and matched normal adjacent tissue, respectively (1 core/case). With survival information. Follow up 5-9 years. Relapse information available.
180
90
$1,440.00
$1,440.00
HColA030PG05
30 cases,tumor
30
15
$94.00
$94.00
HColA160Su02
Colon adenocarcinoma,100 cases, 160 cores.With survival information. 100 cases tumor (1 core/tumor),60 cases (1 core/NAT.)Surgery date from 2005.7-2010.12.visit date 2015.9.Being fowllowed up for 5-9 years. 36 cases deceased.
150
30
$1,250.00
$1,250.00
HColA180Su09
Colon adenocarcinoma,100 cases, 80 cases have tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.
180
100
$1,580.00
$1,580.00
HColA180Su10
Colon adenocarcinoma,100 cases, 80 cases have tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.
180
100
$1,406.00
$1,406.00
HColA180Su11
Colon adenocarcinoma,93 cases, 87 cases have tumor and NAT*.
180
93
$1,406.00
$1,406.00
HColA180Su12
Colon adenoadenocarcinoma,93 cases, 87 cases have tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.
180
93
$1,406.00
$1,406.00
HColA180Su14
Colon adenoadenocarcinoma,90 cases have tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.
180
90
$1,290.00
$1,290.00
HColA180Su15
Colon adenoadenocarcinoma,101 cases, 79 cases have tumor and NAT*.
180
101
$1,580.00
$1,580.00
HColA180Su17
Colon adenoadenocarcinoma,101 cases, 79 cases have tumor and NAT*.With survival information. Follow up 5-9 years. Relapse information available.
180
101
$1,406.00
$1,406.00
HEso-Squ172Sur-01
Esophageal squamous cell ccancer tissue array (86 cases), 78 cases have tumor and matched normal adjacent tissue (1 core/case), with survival data
172
86
$1,250.00
$1,250.00
HEso-Squ172Sur-02
Esophageal squamous cell cancer tissue array (93 cases), 79 cases have tumor and matched normal adjacent tissue (1 core/case), with survival data
172
93
$1,090.00
$1,090.00
HEso-Squ180Sur-01
Esophagus squamous carcinoma, 95 cases, tumor and matched NAT with survival information.
180
95
$1,562.00
$1,562.00
HEso-Squ180Sur-02
Esophagus squamous carcinoma, 90 cases, tumor and matched NAT with survival information.
180
90
$1,250.00
$1,250.00
HEso-Squ180Sur-03
Esophagus squamous cell carcinoma tissue array, 93 cases, tumor and matched NAT with survival information.
180
93
$1,406.00
$1,406.00
HEsoS105Su01
Esophagus squamous cell carcinoma, 50 cases have tumor(1 core/case) and matched NAT* (1 core/case). 5 cases have tumor tissue(2 cores/case).
105
50
$938.00
$938.00
HEsoS180Su04
esophagus carcinoma,100 cases, tumor and matched NAT* with survival information.
180
100
$1,562.00
$1,562.00
HEsoS180Su05
Esophagus carcinoma,103 cases, tumor and matched NAT* with survival information.
180
103
$1,562.00
$1,562.00
HEsoS180Su06
Esophageal cancer tissue array with matched cancer adjacent esophageal tissue and survival information, including pathology grade, TNM and clinical stage, 103 cases/180 cores. With survival information. Follow up 5-9 years. Relapse information available.
180
103
$1,328.00
$1,328.00
HEsoS180Su07
Esophagus squamous cell carcinoma (103 cases), 77 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case).With survival information. Follow up 5-9 years. Relapse information available.
180
103
$1,406.00
$1,406.00
HGal-Ade100PG-01
Gallbladder carcinoma tissue array, 80 cases. 20 cases have tumor and normal adjacent tissue. 60 cases have only tumor
100
80
$465.00
$465.00
HGEj-Ade130Sur-01
Gastroesophageal junctional cancer tissue array, 65 cases and matched normal adjacent tissue, with survival data
130
65
$780.00
$780.00
HKid-CRC180Sur-01
Kidney clear cell carcinoma tissue array, 90 cases of tumor and matched normal adjacent tissue (1 core/case), with survival data
180
90
$1,406.00
$1,406.00
HKid-CRCC150CS-01
Kidney clear cell carcinoma tissue array, 75 cases, tumor and matched normal adjacent tissue.
150
75
$625.00
$625.00
HKidE180Su02
Kidney cancer tissue array with matched cancer adjacent normal tissue and survival information, including pathology grade, TNM and clinical stage, 150 cases/180 cores
180
150
$1,406.00
$1,406.00
HKidE180Su03
Clear cell carcinoma, 90 cases.
180
90
$1,406.00
$1,406.00
HLiv-HCC180Sur-02
HLiver cancer tissue array, 90 cases of tumor and matched normal adjacent tissue (1 core/case), with survival data
180
90
$1,560.00
$1,560.00
HLiv-HCC180Sur-03
Liver cancer tissue array (90 cases) and normal adjacent tissue (NAT), 1 core/case, with survival data
180
90
$1,406.00
$1,406.00
HLiv-HCC180Sur-04
Hepatocellular carcinoma tissue array, clinical stage I-III, 90 cases. Tumor and normal adjacent tissue. With survival data.
180
90
$1,600.00
$1,600.00
HLiv-HCC180Sur-05
Hepatocellular carcinoma tissue array, 95 cases. Tumor and normal adjacent tissue.
180
95
$1,600.00
$1,600.00
HLivH070Su01
Hepatocellular carcinoma, 32 cases. Tumor and NAT*.With survival information. Follow up 5-9 years. Relapse information available
70
32
$469.00
$469.00
HLivH090Su01
Hepatocellular carcinoma, 90 cases.
90
90
$1,875.00
$1,875.00
HLivH150CS04
liver adenocarcinoma, 75 cases.
150
75
$391.00
$391.00
HLivH180Su10
Hepatocellular carcinoma, 90 cases. Tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available.
180
93
$1,562.00
$1,562.00
HLivH180Su14
Hepatocellular carcinoma, 90 cases. Tumor and NAT*. With survival information. Follow up 5-9 years. Relapse information available
180
90
$1,875.00
$1,875.00
HLivHCC180Bch01
Hepatocellular carcinoma, 49 cases. Tumor and NAT*.
180
49
$465.00
$465.00
HLug-Ade060PG-01
Human lung carcinoma tissue array with matched normal adjacent tissue
60
30
$188.00
$188.00
HLug-Ade150Sur-01
Lung adenocarcinoma tissue array, 75 cases of tumor and matched normal adjacent tissue (NAT), 1 core/case with TNM and survival information.
150
75
$935.00
$935.00
HLug-Ade150Sur-02
Lung adenocarcinoma tissue array (75 cases) and matched normal adjacent tissue (1 core/case), with survival data
150
75
$935.00
$935.00
HLug-Squ150Sur-01
Lung squamous cell cancer tissue array, 75 cases. Tumor and matched normal adjacent tissue (NAT), 1 core/case with TNM detail information and survival data.
150
75
$1,090.00
$1,090.00
HLug-Squ150Sur-02
Lung squamous cell carcinoma tissue array (75 cases) and matched normal adjacent tissue (NAT, 1 core/case), with survival data
150
75
$938.00
$938.00
HLugA180Su01
Lung carcinoma,90 cases, tumor and matched NAT* with survival information.
180
90
$1,406.00
$1,406.00
HLugA180Su03
Lung carcinoma,92 cases, tumor and matched NAT* with survival information.replacing Hlug-Ade150Sur-01
180
92
$1,406.00
$1,406.00
HlugA180Su05
Lung cancer with matched adjacent tissue array, including pathology grade, clinical stage(AJCC 7.0)I II III IV, with TNM score, survival information available. Surgery date 2004.7-2009.6, visit date 2014.8. Being followed up for 5-10 years, with FISH information (EGFR), 94 cases/180 cores
180
94
$1,562.00
$1,562.00
HLugA180Su06
Lung carcinoma,94 cases, tumor and matched NAT* with survival information.
180
94
$1,562.00
$1,562.00
HLugS180su-01
Lung squamous carcinoma,90 cases, tumor and matched NAT* with survival information.
180
90
$1,562.00
$1,562.00
HNasN132Su01
Nasopharyngeal carcinoma, tumor only
132
132
$1,875.00
$1,875.00
HOvaC154Su01
Multiple ovary cancer tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage (reference AJCC 7th version), With survival information. Follow up 5-9 years. Relapse information available. Ki67, EGFR, PDL1 information added. 154 cases/154 cores, replacing HOvaC160Su01
154
154
$1,875.00
$1,875.00
HPan-Ade120Sur-01
Pancreatic carcinoma, 63 cases, with survival information.
120
63
$960.00
$960.00
HPan-Ade170Sur-01
Pancreatic adenocarcinoma, 99 cases, tumor and matched NAT*. With survival information. Follow up 5-9 years. Relapse information available.
170
99
$1,406.00
$1,406.00
HPan-Ade180Sur-02
Pancreatic cancer tissue array, 90 cases of carcinoma and matched normal adjacent tissue (nat, 1 core/case), with survival data. With survival information. Follow up 5-9 years. Relapse information available.
100
100
$1,560.00
$1,560.00
HPanA020PG02
10 cases,tumor and NAT
20
10
$78.00
$78.00
HPro-Ade96Sur-01
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores and survival data, 40 cases/96 cores
95
40
$1,560.00
$1,560.00
HRaU-Uro050Sur-01
Normal adjacent tissue of urothelium carcinoma,50 cases, with survival information.
50
50
$156.00
$156.00
HRaU-Uro120Sur-01
Renal pelvis carcinoma and ureter carcinoma tissue array, 120 cases, 1 core/case, with survival data
120
120
$780.00
$780.00
HRec-Ade180Sur-01
Rectal cancer tissue array (90 cases) and matched normal adjacent tissue, with survival data
180
90
$1,250.00
$1,250.00
HRec-Ade180Sur-02
Rectal cancer tissue array (90 cases) and matched normal adjacent tissue, with survival data
180
90
$1,090.00
$1,090.00
HRec-Ade180Sur-03
Rectum adenocarcinoma tissue microarray with survival information, with matched normal adjacent tissue, 90 cases/180 cores;
180
90
$1,484.00
$1,484.00
HRec-Ade180Sur-04
Rectum adenocarcinoma tissue microarray with survival information, with matched normal adjacent tissue, 90 cases/180 cores
180
90
$1,406.00
$1,406.00
HRec-Ade180Sur-05
Rectum adenocarcinoma (90 cases), tumor and matched NAT*.With survival information. Follow up 5-9 years. Relapse information available
180
90
$1,250.00
$1,250.00
HSkiC100PT01
Skin carcinoma, 95 cases. Include basal cell carcinoma, squamous cell carcinoma, melanoma. Normal skin, 3 cases. 15 cases have survival information.
100
95
$312.00
$312.00
HStm-A150Su-01
gastric carcinoma, 75 cases. With survival information. Follow up 5-9 years. Relapse information available
150
95
$1,288.00
$1,288.00
HStm-Ade167Sur-01
Stomach cancer tissue array (92 cases) and matched normal adjacent tissue, with survival data
167
92
$1,250.00
$1,250.00
HStm-Ade178Sur-01
Stomach cancer tissue array (111 cases). 67 cases have tumor and matched (NAT), with survival data
178
111
$1,560.00
$1,560.00
HStm-Ade180Sur-02
Stomach cancer tissue array, 90 cases/180 cores. With survival information. Follow up 5-9 years. Relapse information available.
180
90
$1,090.00
$1,090.00
HStm-Ade180Sur-03
Gastric adenocarcinoma,90 cases, tumor and matched NAT* .With survival information. Follow up 5-9 years. Relapse information available.
180
90
$1,406.00
$1,406.00
HStm-Ade180Sur-04
Stomach cancer tissue array, 90 cases, tumor and matched normal adjacent tissue (NAT), with survival data
180
90
$1,484.00
$1,484.00
HStm-Ade180Sur-05
Gastric adenocarcinoma tissue array,90 cases, tumor and matched normal adjacent tissue with survival information
180
90
$1,484.00
$1,484.00
$714.00
HStm-Ade180Sur-06
Gastric adenocarcinoma,90 cases, tumor and matched NAT* with survival information.
180
90
$1,328.00
$1,328.00
HStm-Ade180Sur-07
Stomach cancer tissue array, 90 cases, tumor and matched normal adjacent tissue (NAT) with survival information.
180
90
$1,250.00
$1,250.00
$380.00
HStmA180Su08
Stomach cancer tissue array with matched adjacent normal stomach tissue, including pathology grade, TNM and clinical stage, 100 cases/180 cores. With survival information. Follow up 5-9 years. Relapse information available.
180
100
$1,580.00
$1,580.00
HStmA180Su09
gastric adenocarcinoma, 90 cases, tumor and NAT*.
180
90
$1,406.00
$1,406.00
HStmA180Su11
gastric adenocarcinoma, 90 cases, 90 cases have tumor and NAT*.
180
90
$1,406.00
$1,406.00
HStmA180Su13
Gastric adenocarcinoma, 96 cases, 84 cases have tumor and NAT*, 12cases have tumor only. With survival information. Follow up 5-9 years. Relapse information available
180
96
$1,250.00
$1,250.00
HStmA180Su15
Gastric adenocarcinoma, 96 cases, 82 cases have tumor and NAT*, 16 cases have tumor only. With survival information. Follow up 5-9 years. Relapse information available
180
98
$1,563.00
$1,563.00
HUteS168Su01
Human cervix tissue .With survival information. Follow up 5-9 years. Relapse information available.
168
126
$1,406.00
$1,406.00
1
2
>
>|
Showing 1 to 100 of 141 (2 Pages)